VTGN - VistaGen Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (3Y Monthly) -0.21
52-Week Change 3-43.60%
S&P500 52-Week Change 37.98%
52 Week High 32.2900
52 Week Low 30.3800
50-Day Moving Average 31.0351
200-Day Moving Average 30.8368

Share Statistics

Avg Vol (3 month) 3321.58k
Avg Vol (10 day) 3245.46k
Shares Outstanding 542.62M
Float 37.52M
% Held by Insiders 16.75%
% Held by Institutions 113.61%
Shares Short (Sep 30, 2019) 42.08M
Short Ratio (Sep 30, 2019) 45.29
Short % of Float (Sep 30, 2019) 44.91%
Short % of Shares Outstanding (Sep 30, 2019) 44.89%
Shares Short (prior month Aug 30, 2019) 41.47M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 220/1
Last Split Date 3Aug 14, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2019
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-156.64%
Return on Equity (ttm)-451.36%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -26.47M
Net Income Avi to Common (ttm)-27.75M
Diluted EPS (ttm)-0.8290
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.3M
Total Cash Per Share (mrq)0.19
Total Debt (mrq)4.49M
Total Debt/Equity (mrq)79.10
Current Ratio (mrq)2.65
Book Value Per Share (mrq)0.04

Cash Flow Statement

Operating Cash Flow (ttm)-16.15M
Levered Free Cash Flow (ttm)-11.08M